EDC eNewsletter September 2008
Applied Clinical Trials' EDC News brings you the latest headlines, features, and resources for everything EDC, from new software to company innovations to IT-related regulations.
invivodata
Register for the Webinar "ePRO Regulatory Environment in Europe" designed to help researchers make decisions about their PRO strategy for clinical programs.
Experience a New Dimension
ClinPhone’s combined EDC-IVR solution provides a single platform for delivering clinical trial logistics and data management. Contact us today:
October 6–8, 2008
Location | Brussels, Belgium
October 30, 2008
Location | Takeda, London
October 29–30, 2008
Location | Philadelphia, PA
joins Octagon as senior consultant of clinical data strategies.
has been added as a new associate to the Waife & Associates' staff.
joins Nextrials as the new chief technology officer.
Applied Clinical Trials will release its EDC & Information Technology supplement with the
Octagon Research Solutions has added an
ClinPage has amassed its
You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025